abstract |
The present invention describes novel compounds that inhibit the activity of LRRK2 kinase, the methods of preparing them, the compositions containing them, as well as the use in the treatment of diseases characterized by activity of LRRK2 kinase, particularly Parkinson's disease and disease Alzheimer's |